China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A retrospective study evaluating the efficacy of roxadustat in renal anemia'. The follow... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of exercise on sarcopenia in people with dialysis: a randomized controlled tr... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multimodal MRI study on neural plasticity in longitudinal neurorehabilitation training... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, double-blind, placebo-controlled, parallel-group phase III trial to evalua... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized controlled study on the effectiveness of medical recombinant collagen care ... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Automated CT/MRI Body Composition in Relation to Health, Aging, and Multimorbidity: A Na... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of Clinical Characteristics and Genetic Susceptibility of Patellofemoral Joint ... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of lubiprostone in the treatment of Slow-Transit Constipation'. The ... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Durvalumab combined with S-1 as adjuvant therapy for resectable Biliary Tract Cancer'. T... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of the safety and efficacy of the Great Wall stent and Enterprise2 stent-assi... Read More